PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2024European Journal of Clinical Microbiology & Infectious Diseases26 citationsOpen Access

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study

View Full Paper
AOAlessandra OlivaLLL LiguoriSCS. Covino

Key Points

Key points are not available for this paper at this time.

Abstract

We assessed the clinical effectiveness of cefiderocol (CFDC) in comparison with colistin (COL) for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections (BSI).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Oliva et al. (2024) studied this question.

synapsesocial.com/papers/68e6e8a8b6db64358766362fhttps://doi.org/10.1007/s10096-024-04833-8
Ask AI
Helpful
Bookmark
Share
View Full Paper